Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Regulatory News (LID)

  • There is currently no data for LID

Blocklisting Application

27 Jan 2014 16:10

RNS Number : 6167Y
LiDCO Group Plc
27 January 2014
 



 

27 January 2014 LiDCO Group Plc

("LiDCO" or the "Company")

Blocklisting Application

LiDCO Group Plc (AIM:LID), the cardiovascular monitoring company, announces that application has been made for the block admission of up to 3,200,000 ordinary shares of 0.5 pence each ("Ordinary Shares").

These Ordinary Shares will be available to be issued to satisfy the future potential exercise of options under the terms of the LiDCO Group Plc Executive Share Option Scheme adopted on 6 June 2001 comprising Part A (Approved.), Part B (Unapproved), and Part C (Incentive Stock Options), the LiDCO Group Plc Enterprise Management Incentive Scheme 2002, the LiDCO Group Plc Unapproved Share Option Plan 2005, the LiDCO Group Plc Enterprise Management Incentive Scheme 2013 and the LIDCO Group Plc Consultants Share Option Scheme 2003.

All Ordinary Shares issued pursuant to the exercise of options under the Share Option Plans will rank pari passu with the existing Ordinary Shares. It is expected that the block admission will become effective on 31 January 2014.

For further information, please contact:

 

LiDCO Group Plc

www.lidco.com

Terry O'Brien (CEO)

Tel: +44 (0)20 7749 1500

Paul Clifford (Finance Director)

 

 

 

finnCap

Tel: +44 (0)20 7600 1658

Geoff Nash / Henrik Persson (Corporate Finance)

 

Stephen Norcross (Corporate Broking)

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 or lidco@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISEAKFXAEXLEFF
Date   Source Headline
5th Dec 20077:00 amPRNClinical Study Results
16th Nov 20077:00 amPRNPlacing of Shares
30th Oct 20077:00 amPRNInterim Results
29th Aug 20077:00 amPRNTrading Statement
15th Aug 20073:11 pmPRNAIM Rule 26
31st Jul 200712:45 pmPRNDirector/PDMR Shareholding
17th Jul 20077:00 amPRNAnnual Report and Accounts
28th Jun 20079:35 amPRNDirector/PDMR Shareholding
25th Jun 20075:14 pmPRNGrant of Options
22nd Jun 200710:45 amPRNAGM Result
21st Jun 20077:00 amPRNTrading Update & AGM Statement
20th Jun 20077:00 amPRNUS Patent Grant
14th Jun 20078:57 amRNSHolding(s) in Company
7th Jun 20077:00 amPRNBD Collaboration
9th May 20077:00 amPRNApproval of Products in South Korea
24th Apr 20073:10 pmPRNNotice of AGM
19th Apr 20077:00 amPRNPreliminary Results
29th Mar 20077:00 amPRNClinical Study Data
26th Mar 20077:00 amPRNNotice of Results & AGM
21st Mar 20077:00 amPRNRelease of LiDCOlive
20th Mar 20072:28 pmRNSHolding(s) in Company
20th Mar 20071:56 pmRNSHolding(s) in Company
20th Mar 200712:55 pmRNSHolding(s) in Company
19th Mar 20074:33 pmRNSHolding(s) in Company
19th Mar 20073:22 pmPRNDirector/PDMR Shareholding
19th Mar 20073:21 pmPRNDirector/PDMR Shareholding
16th Mar 20074:54 pmRNSHolding(s) in Company
23rd Feb 20077:00 amPRNTrading Update
1st Feb 20074:11 pmPRNVoting Rights & Capital
26th Jan 20074:47 pmPRNAdditional Listing
23rd Jan 20077:00 amPRNPediatric Study
22nd Jan 20075:48 pmPRNDirectorate Change
15th Dec 200610:31 amPRNTotal Voting Rights
28th Nov 20067:00 amPRNTrading Update
18th Oct 20067:00 amPRNInterim Results
9th Oct 20062:00 pmPRNNew Software
3rd Oct 20067:00 amPRNR & D Day
25th Sep 20067:00 amPRNShare Listing
19th Sep 20067:00 amPRNContract Extension
22nd Aug 20067:00 amPRNTrading Update
25th Jul 20065:53 pmPRNDirector/PDMR Shareholding
23rd Jun 20064:51 pmPRNGrant of Options
6th Jun 20067:00 amPRNProduct Registration in Switzerland
23rd May 20064:10 pmPRNResult of EGM
28th Apr 200612:58 pmPRNPlacing
28th Apr 200612:57 pmPRNFinal Results
25th Apr 20066:20 pmPRNChange of results day
25th Apr 20067:00 amPRNSoftware Link with Picis
28th Mar 20067:00 amPRNAward Win
14th Feb 20067:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.